We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

RNA-Seq – News and Features

News

GATC Biotech will use Genome Sequencer Technology from Roche

GATC plans to use the Genome Sequencer to offer its customers all the applications within this technology, with a special focus on in-depth analysis of whole transcriptomes.
News

Compendia Bioscience and Ingenuity Partner to Integrate Cancer Gene Signature Data with Network Analysis Tools

The integrated products will allow users to navigate directly from cancer gene signatures discovered in Oncomine Professional to the pathway information from IPA.
News

Genedata Expands Collaboration with HepatoSys

Swiss-based computational biology provider Genedata AG announced a three-year expansion of their collaboration with the HepatoSys research network.
News

Sigma-Aldrich Signs Exclusive Agreement with Rubicon Genomics to Commercialize Transplex™

Rubicon Genomics will develop the TransPlex™ WTA technology which can be used for amplifying total RNA from a variety of sample sources.
News

Three Cancer Genome Characterization Centers Select Agilent’s Microarray Platform to Profile Cancers

All three institutions will rely on Agilent’s genomics solution, comprising microarrays, reagents, hardware and data analysis tools.
News

Cenix, Applied Biosystems and Dresden University Announce Collaboration

Collaboration to create facility for proteomics profiling of RNAi and drug effects in human cells.
News

Compugen Discloses Status of In Silico Discovered Therapeutic Candidates

Molecules targeted at various cancers, inflammatory diseases and cardio-vascular indications.
News

Three Cancer Genome Characterization Centers Select Agilent’s Microarray Platform to Profile Cancers

All three institutions will rely on Agilent’s genomics solution, comprising microarrays, reagents, hardware and data analysis tools.
News

Roche Sells Genome Sequencer 20 to DYN

DYN G.S. is aiming to become a specialized center for providing sequencing services.
News

Within the Next 10 Years it is Anticipated that Metabolomics will Become a Standard Tool in the Pharma Industry

Research and Markets announces the addition of "The Future of Metabolomics: Building Competitive Advantage in Drug Discovery, Clinical Development and Diagnostics"
Advertisement